A detailed history of Acuitas Investments, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Acuitas Investments, LLC holds 438,760 shares of AADI stock, worth $1.25 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
438,760
Previous 352,483 24.48%
Holding current value
$1.25 Million
Previous $514,000 75.68%
% of portfolio
0.43%
Previous 0.29%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$1.32 - $2.06 $113,885 - $177,730
86,277 Added 24.48%
438,760 $903,000
Q2 2024

Aug 05, 2024

BUY
$1.46 - $2.31 $50,142 - $79,334
34,344 Added 10.8%
352,483 $514,000
Q1 2024

May 10, 2024

BUY
$1.59 - $2.44 $505,841 - $776,259
318,139 New
318,139 $744,000

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $60.1M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.